VECTORY
Summary
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science and technologies.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Sander van Deventer
CEO
Michael Wyzga
CFO